Geode Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$55.6M Buy
488,778
+24,326
+5% +$2.77M ﹤0.01% 1368
2025
Q1
$48.8M Buy
464,452
+26,011
+6% +$2.74M ﹤0.01% 1390
2024
Q4
$47M Buy
438,441
+10,171
+2% +$1.09M ﹤0.01% 1476
2024
Q3
$42.9M Buy
428,270
+22,495
+6% +$2.25M ﹤0.01% 1515
2024
Q2
$34.2M Buy
405,775
+24,805
+7% +$2.09M ﹤0.01% 1617
2024
Q1
$27.9M Buy
380,970
+10,155
+3% +$742K ﹤0.01% 1726
2023
Q4
$26.5M Buy
370,815
+18,194
+5% +$1.3M ﹤0.01% 1741
2023
Q3
$21.1M Buy
352,621
+11,008
+3% +$660K ﹤0.01% 1787
2023
Q2
$24.6M Buy
341,613
+24,814
+8% +$1.79M ﹤0.01% 1713
2023
Q1
$23.3M Buy
316,799
+16,129
+5% +$1.19M ﹤0.01% 1686
2022
Q4
$20.1M Sell
300,670
-164,376
-35% -$11M ﹤0.01% 1770
2022
Q3
$25M Sell
465,046
-986
-0.2% -$53K ﹤0.01% 1571
2022
Q2
$25.9M Sell
466,032
-15,825
-3% -$881K ﹤0.01% 1569
2022
Q1
$33.8M Buy
481,857
+25,542
+6% +$1.79M ﹤0.01% 1531
2021
Q4
$44M Buy
456,315
+13,863
+3% +$1.34M 0.01% 1397
2021
Q3
$38.5M Sell
442,452
-2,477
-0.6% -$215K 0.01% 1492
2021
Q2
$36.4M Buy
444,929
+23,539
+6% +$1.93M 0.01% 1572
2021
Q1
$40.1M Buy
421,390
+46,597
+12% +$4.43M 0.01% 1404
2020
Q4
$23.3M Buy
374,793
+3,160
+0.9% +$196K ﹤0.01% 1629
2020
Q3
$22.1M Sell
371,633
-14,502
-4% -$862K ﹤0.01% 1469
2020
Q2
$26.9M Sell
386,135
-30,361
-7% -$2.12M 0.01% 1279
2020
Q1
$18.9M Buy
416,496
+15,897
+4% +$721K ﹤0.01% 1328
2019
Q4
$26.1M Sell
400,599
-12,165
-3% -$791K 0.01% 1387
2019
Q3
$25.6M Sell
412,764
-7,650
-2% -$475K 0.01% 1310
2019
Q2
$29.9M Buy
420,414
+4,038
+1% +$288K 0.01% 1199
2019
Q1
$32.7M Buy
416,376
+18,095
+5% +$1.42M 0.01% 1086
2018
Q4
$33.7M Buy
398,281
+33,292
+9% +$2.82M 0.01% 941
2018
Q3
$62.5M Buy
364,989
+11,308
+3% +$1.94M 0.02% 698
2018
Q2
$45.7M Buy
353,681
+36,404
+11% +$4.7M 0.01% 811
2018
Q1
$32.7M Buy
317,277
+12,409
+4% +$1.28M 0.01% 954
2017
Q4
$26M Buy
304,868
+16,039
+6% +$1.37M 0.01% 1086
2017
Q3
$24.5M Buy
288,829
+3,081
+1% +$262K 0.01% 1086
2017
Q2
$21.6M Buy
285,748
+27,308
+11% +$2.07M 0.01% 1117
2017
Q1
$17.1M Buy
258,440
+10,804
+4% +$713K 0.01% 1269
2016
Q4
$15.7M Buy
247,636
+7,927
+3% +$502K 0.01% 1269
2016
Q3
$15.3M Buy
239,709
+5,911
+3% +$376K 0.01% 1192
2016
Q2
$17.4M Buy
233,798
+22,805
+11% +$1.7M 0.01% 1039
2016
Q1
$14.1K Buy
210,993
+4,252
+2% +$284 0.01% 1138
2015
Q4
$14M Buy
206,741
+5,752
+3% +$389K 0.01% 1134
2015
Q3
$10.7M Buy
200,989
+571
+0.3% +$30.5K 0.01% 1294
2015
Q2
$12.6M Buy
200,418
+12,853
+7% +$809K 0.01% 1245
2015
Q1
$9.02M Buy
187,565
+2,556
+1% +$123K 0.01% 1466
2014
Q4
$6.14M Sell
185,009
-18,971
-9% -$630K ﹤0.01% 1694
2014
Q3
$5.98M Buy
203,980
+19,204
+10% +$563K ﹤0.01% 1643
2014
Q2
$7.18M Sell
184,776
-14,293
-7% -$555K ﹤0.01% 1555
2014
Q1
$8.35M Buy
199,069
+38,678
+24% +$1.62M 0.01% 1382
2013
Q4
$5.26M Buy
160,391
+10,196
+7% +$335K ﹤0.01% 1665
2013
Q3
$4.06M Buy
150,195
+8,176
+6% +$221K ﹤0.01% 1715
2013
Q2
$3.32M Buy
+142,019
New +$3.32M ﹤0.01% 1718